Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory

[1]  H. Vinters,et al.  Pre‐synaptic C‐terminal truncated tau is released from cortical synapses in Alzheimer's disease , 2015, Journal of neurochemistry.

[2]  M. Diamond,et al.  Tau Trimers Are the Minimal Propagation Unit Spontaneously Internalized to Seed Intracellular Aggregation* , 2015, The Journal of Biological Chemistry.

[3]  M. Frotscher,et al.  Pro-aggregant Tau impairs mossy fiber plasticity due to structural changes and Ca++ dysregulation , 2015, Acta neuropathologica communications.

[4]  D. Puzzo,et al.  Intracellular Accumulation of Amyloid-β (Aβ) Protein Plays a Major Role in Aβ-Induced Alterations of Glutamatergic Synaptic Transmission and Plasticity , 2014, The Journal of Neuroscience.

[5]  M. Diamond,et al.  Prion-like Properties of Tau Protein: The Importance of Extracellular Tau as a Therapeutic Target* , 2014, The Journal of Biological Chemistry.

[6]  E. Mandelkow,et al.  Stages and Conformations of the Tau Repeat Domain during Aggregation and Its Effect on Neuronal Toxicity* , 2014, The Journal of Biological Chemistry.

[7]  D. Holtzman,et al.  Neuronal activity regulates extracellular tau in vivo , 2014, The Journal of experimental medicine.

[8]  M. Tolnay,et al.  Intercellular transfer of tau aggregates and spreading of tau pathology: Implications for therapeutic strategies , 2014, Neuropharmacology.

[9]  Clemens F. Kaminski,et al.  Extracellular Monomeric Tau Protein Is Sufficient to Initiate the Spread of Tau Protein Pathology* , 2013, The Journal of Biological Chemistry.

[10]  M. Sierks,et al.  Trimeric Tau Is Toxic to Human Neuronal Cells at Low Nanomolar Concentrations , 2013, International journal of cell biology.

[11]  E. Mufson,et al.  Prefibrillar Tau Oligomers in Mild Cognitive Impairment and Alzheimer's Disease , 2013, Neurodegenerative Diseases.

[12]  G. Hall,et al.  Tangles, Toxicity, and Tau Secretion in AD – New Approaches to a Vexing Problem , 2013, Front. Neurol..

[13]  Wendy Noble,et al.  Physiological release of endogenous tau is stimulated by neuronal activity , 2013, EMBO reports.

[14]  O. Arancio,et al.  Synthesis of quinoline derivatives: discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer's disease. , 2013, European journal of medicinal chemistry.

[15]  C. Zurzolo,et al.  Small Misfolded Tau Species Are Internalized via Bulk Endocytosis and Anterogradely and Retrogradely Transported in Neurons* , 2012, The Journal of Biological Chemistry.

[16]  U. Sengupta,et al.  Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau , 2012, Scientific Reports.

[17]  B. Hyman,et al.  Soluble forms of tau are toxic in Alzheimer’s disease , 2012, Translational neuroscience.

[18]  J. Lancia,et al.  Tau oligomers and tau toxicity in neurodegenerative disease. , 2012, Biochemical Society transactions.

[19]  U. Sengupta,et al.  Identification of oligomers at early stages of tau aggregation in Alzheimer's disease , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  A. Andreadis,et al.  Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transport , 2012, Neurobiology of Aging.

[21]  D. Holtzman,et al.  Tau elevations in the brain extracellular space correlate with reduced amyloid-β levels and predict adverse clinical outcomes after severe traumatic brain injury. , 2012, Brain : a journal of neurology.

[22]  D. Holtzman,et al.  Trans-cellular Propagation of Tau Aggregation by Fibrillar Species* , 2012, The Journal of Biological Chemistry.

[23]  Naruhiko Sahara,et al.  Propagation of Tau Pathology in a Model of Early Alzheimer's Disease , 2012, Neuron.

[24]  Menno P. Witter,et al.  Trans-Synaptic Spread of Tau Pathology In Vivo , 2012, PloS one.

[25]  A. Palamara,et al.  HSV-1 promotes Ca2+-mediated APP phosphorylation and Aβ accumulation in rat cortical neurons , 2011, Neurobiology of Aging.

[26]  A. Andreadis,et al.  Pathogenic Forms of Tau Inhibit Kinesin-Dependent Axonal Transport through a Mechanism Involving Activation of Axonal Phosphotransferases , 2011, The Journal of Neuroscience.

[27]  Giovanni B. Frisoni,et al.  The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers , 2011, Alzheimer's & Dementia.

[28]  N. Nukina,et al.  Tau Protein Assembles into Isoform- and Disulfide-dependent Polymorphic Fibrils with Distinct Structural Properties* , 2011, The Journal of Biological Chemistry.

[29]  Meaghan Morris,et al.  The Many Faces of Tau , 2011, Neuron.

[30]  M. Glucksman,et al.  Characterization of Prefibrillar Tau Oligomers in Vitro and in Alzheimer Disease* , 2011, The Journal of Biological Chemistry.

[31]  I. Heuser,et al.  Comparison of Immunosorbent Assays for the Quantification of Biomarkers for Alzheimer’s Disease in Human Cerebrospinal Fluid , 2011, Dementia and Geriatric Cognitive Disorders.

[32]  R. Kayed,et al.  Preparation and characterization of neurotoxic tau oligomers. , 2010, Biochemistry.

[33]  Sangmook Lee,et al.  Secretion of human tau fragments resembling CSF‐tau in Alzheimer's disease is modulated by the presence of the exon 2 insert , 2010, FEBS letters.

[34]  O. Arancio,et al.  Preparation of oligomeric beta-amyloid 1-42 and induction of synaptic plasticity impairment on hippocampal slices. , 2010, Journal of visualized experiments : JoVE.

[35]  J. Trojanowski,et al.  Characterization of tau fibrillization in vitro , 2010, Alzheimer's & Dementia.

[36]  P. Davies,et al.  Age-Dependent Impairment of Cognitive and Synaptic Function in the htau Mouse Model of Tau Pathology , 2009, The Journal of Neuroscience.

[37]  Martin Beibel,et al.  Transmission and spreading of tauopathy in transgenic mouse brain , 2009, Nature Cell Biology.

[38]  M. Diamond,et al.  Propagation of Tau Misfolding from the Outside to the Inside of a Cell* , 2009, Journal of Biological Chemistry.

[39]  Bradley T. Hyman,et al.  Tau pathophysiology in neurodegeneration: a tangled issue , 2009, Trends in Neurosciences.

[40]  A. Kozikowski,et al.  The amino terminus of tau inhibits kinesin‐dependent axonal transport: Implications for filament toxicity , 2009, Journal of neuroscience research.

[41]  M. Sierks,et al.  Characterizing antibody specificity to different protein morphologies by AFM. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[42]  A. Palmeri,et al.  Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus , 2008, The Journal of Neuroscience.

[43]  M. Novák,et al.  High-yield purification of fetal tau preserving its structure and phosphorylation pattern. , 2008, Journal of immunological methods.

[44]  Z. Khachaturian.  Alzheimer's & Dementia: The Journal of the Alzheimer's Association , 2008, Alzheimer's & Dementia.

[45]  S. Maeda,et al.  Assembly of two distinct dimers and higher‐order oligomers from full‐length tau , 2007, The European journal of neuroscience.

[46]  K. Ashe,et al.  Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy , 2007, The Journal of Neuroscience.

[47]  D. Diamond,et al.  Two-day radial-arm water maze learning and memory task; robust resolution of amyloid-related memory deficits in transgenic mice , 2006, Nature Protocols.

[48]  Steven Mennerick,et al.  Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo , 2005, Neuron.

[49]  H. Liebig,et al.  Rapid purification of truncated tau proteins: model approach to purification of functionally active fragments of disordered proteins, implication for neurodegenerative diseases. , 2004, Protein expression and purification.

[50]  Ottavio Arancio,et al.  Presynaptic CaMKII Is Necessary for Synaptic Plasticity in Cultured Hippocampal Neurons , 2004, Neuron.

[51]  J. Ávila,et al.  Quinones facilitate the self-assembly of the phosphorylated tubulin binding region of tau into fibrillar polymers. , 2004, Biochemistry.

[52]  C. Barbato,et al.  Role of N-terminal tau domain integrity on the survival of cerebellar granule neurons , 2004, Cell Death and Differentiation.

[53]  C. Finch,et al.  Self-assembly of Aβ1-42 into globular neurotoxins , 2003 .

[54]  P. Davies,et al.  Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms , 2003, Journal of neurochemistry.

[55]  R. Malinow,et al.  APP Processing and Synaptic Function , 2003, Neuron.

[56]  E. Kandel,et al.  Rapid Increase in Clusters of Presynaptic Proteins at Onset of Long-Lasting Potentiation , 2001, Science.

[57]  D. Wilson,et al.  Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease. , 1997, The American journal of pathology.

[58]  E. Mandelkow,et al.  RNA stimulates aggregation of microtubule‐associated protein tau into Alzheimer‐like paired helical filaments , 1996, FEBS letters.

[59]  R. Crowther,et al.  Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans , 1996, Nature.

[60]  J. Ávila,et al.  Polymerization of τ into Filaments in the Presence of Heparin: The Minimal Sequence Required for τ ‐ τ Interaction , 1996 .

[61]  Joseph E LeDoux,et al.  Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. , 1992, Behavioral neuroscience.

[62]  Deborah Moran,et al.  Data-independent acquisition (MSE) with ion mobility provides a systematic method for analysis of a bacteriophage structural proteome. , 2014, Journal of virological methods.

[63]  U. Sengupta,et al.  Specific targeting of tau oligomers in Htau mice prevents cognitive impairment and tau toxicity following injection with brain-derived tau oligomeric seeds. , 2014, Journal of Alzheimer's disease : JAD.

[64]  J. Lancia,et al.  TOC1: characterization of a selective oligomeric tau antibody. , 2013, Journal of Alzheimer's disease : JAD.

[65]  Sangmook Lee,et al.  Interneuronal transfer of human tau between Lamprey central neurons in situ. , 2010, Journal of Alzheimer's disease : JAD.

[66]  John Q Trojanowski,et al.  Evidence that non-fibrillar tau causes pathology linked to neurodegeneration and behavioral impairments. , 2008, Journal of Alzheimer's disease : JAD.

[67]  David M Holtzman,et al.  Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. , 2005, Neuron.

[68]  H. Braak,et al.  A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads , 2004, Acta Neuropathologica.

[69]  C. Finch,et al.  Self-assembly of Abeta(1-42) into globular neurotoxins. , 2003, Biochemistry.

[70]  J. Ávila,et al.  Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction. , 1996, Journal of neurochemistry.